首页|期刊导航|国际肝胆胰疾病杂志(英文版)|Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure

Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure

Phillipp Hartmann Sonja Lang Robert Schierwagen Sabine Klein Michael Praktiknjo Jonel Trebicka Bernd Schnabl

国际肝胆胰疾病杂志(英文版)2023，Vol.22Issue(5)：474-481,8.

国际肝胆胰疾病杂志(英文版)2023，Vol.22Issue(5)：474-481,8.DOI:10.1016/j.hbpd.2023.05.003

Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure

Phillipp Hartmann ¹Sonja Lang ²Robert Schierwagen ³Sabine Klein ³Michael Praktiknjo ³Jonel Trebicka ⁴Bernd Schnabl⁵

作者信息

1. Department of Pediatrics,University of California San Diego,La Jolla,CA,USA||Division of Gastroenterology,Hepatology & Nutrition,Rady Children's Hospital San Diego,San Diego,CA,USA
2. Department of Medicine,University of California San Diego,La Jolla,CA,USA||Department of Gastroenterology and Hepatology,Faculty of Medicine,University of Cologne,University Hospital Cologne,Cologne,Germany
3. Department of Internal Medicine B,University of Münster,Münster,Germany
4. Department of Internal Medicine B,University of Münster,Münster,Germany||European Foundation for the Study of Chronic Liver Failure,Barcelona,Spain
5. Department of Medicine,University of California San Diego,La Jolla,CA,USA||Department of Medicine,VA San Diego Healthcare System,San Diego,CA,USA
折叠

摘要

关键词

Liver disease/Acute decompensation/Acute-on-chronic liver failure/Microbiome/Model for end-stage liver disease

Key words

Liver disease/Acute decompensation/Acute-on-chronic liver failure/Microbiome/Model for end-stage liver disease

引用本文复制引用

Phillipp Hartmann,Sonja Lang,Robert Schierwagen,Sabine Klein,Michael Praktiknjo,Jonel Trebicka,Bernd Schnabl..Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure[J].国际肝胆胰疾病杂志(英文版),2023,22(5):474-481,8.

基金项目

This study was supported in part by National Institutes of Health(NIH)grant(K12 HD85036) （NIH）

University of California San Diego Altman Clinical and Translational Research Institute(AC-TRI)/NIH grant(KL2TR001444) （AC-TRI）

Pinnacle Research Award in Liver Diseases Grant(PNC22-159963)from the American Association for the Study of Liver Diseases Foundation(to Hartmann P) （PNC22-159963）

Deutsche Forschungsgemeinschaft(DFG,German Research Foundation)fel-lowship(LA 4286/1-1) （DFG,German Research Foundation）

the"Clinical and Translational Research Fellowship in Liver Disease"by the American Association for the Study of Liver Diseases(AASLD)Foundation(to Lang S),by National Institutes of Health grants(R01 AA24726,R01 AA020703,U01AA026939),and by Award Number BX004594 from the Biomed-ical Laboratory Research & Development Service of the VA Of-fice of Research and Development （AASLD）

Biocodex Microbiota Foundation Grant(to Schnabl B)and services provided by NIH centers(P30DK120515 and P50 AA011999).This study was also supported by the German Research Foundation(DFG)project(403224013-SFB1382)(to Trebicka J) （to Schnabl B）

the German Federal Ministry of Education and Research(BMBF)for the DEEP-HCC project(to Trebicka J) （BMBF）

and the Hessian Ministry of Higher Education,Research and the Arts(HMWK)for the ENABLE and ACLF-I cluster projects(to Trebicka J).The MICROB-PREDICT(825694),DECISION(847949),GALAXY(668031),LIVERHOPE(731875),and IHMCSA(964590)projects(all to Trebicka J)have received funding from the European Union's Horizon 2020 research and innovation program. （HMWK）

国际肝胆胰疾病杂志(英文版)

OACSCD

ISSN：1499-3872

访问量7

下载量0

段落导航